Brevetti EPO No.3413894 2020.03.11
Brevetti EPO
(10) Registration Number and Date
2020000348 2020.07.01
Status
Registered
(180) Expiration Date
(20) Filing Number and Date
SM /T/2020/000348 2017.02.10
(40) Publication Number and Date
SM /T/2020/000348 2020.07.01
(30) Priority Details
EP 16186188
2016.08.29
EP 16155123
2016.02.10
(71/73) Applicant
(72) Inventor
(IT) DE BUCK, Stefan : Novartis Pharma AGNovartis Institutes for Biomed. ResearchPostfach, 4002 Basel, CH
(IT) BIETH, Bruno : Novartis Pharma AGNovartis Institutes for Biomed. ResearchPostfach, 4002 Basel, CH
(IT) CHRIST, Andreas : Novartis Pharma AGNovartis Institutes for Biomed. ResearchPostfach, 4002 Basel, CH
(IT) BURKHART, Christoph : Novartis Pharma AGNovartis Institutes for Biomed. ResearchPostfach, 4002 Basel, CH
(IT) KALIS, Christoph : Novartis Pharma AGNovartis Institutes for Biomed. ResearchPostfach, 4002 Basel, CH
(IT) LINDGREN, Sam : Novartis Pharma AGNovartis Institutes for Biomed. ResearchPostfach, 4002 Basel, CH
(74) Representative Name
(IT) MAROSCIA, Antonio : Piazza E. Enriquez, 22c, 47891 Dogana RSM, SM
(54) Title
(IT) USO DI INIBITORI DELL'ATTIVITA' O DELLA FUNZIONE DI PI3K PER IL TRATTAMENTO DELLA SINDROME DI SJÖGREN PRIMARIA
(EN) USE OF INHIBITORS OF THE ACTIVITY OR FUNCTION OF PI3K FOR THE TREATMENT OF PRIMARY SJÖGREN'S SYNDROME
(57) Abstract
(58) Citations